Literature DB >> 21962810

Gene targeting and cloning in pigs using fetal liver derived cells.

Sanjeev K Waghmare1, Jose Estrada, Luz Reyes, Ping Li, Bess Ivary, Richard A Sidner, Chris Burlak, A Joseph Tector.   

Abstract

BACKGROUND: Since there are no pig embryonic stem cells, pig genetic engineering is done in fetal fibroblasts that remain totipotent for only 3 to 5 wk. Nuclear donor cells that remain totipotent for longer periods of time would facilitate complicated genetic engineering in pigs. The goal of this study was to test the feasibility of using fetal liver-derived cells (FLDC) to perform gene targeting, and create a genetic knockout pig.
MATERIALS AND METHODS: FLDC were isolated and processed using a human liver stem cell protocol. Single copy α-1,3-galactosyl transferase knockout (GTKO) FLDCs were created using electroporation and neomycin resistant colonies were screened using PCR. Homozygous GTKO cells were created through loss of heterozygosity mutations in single GTKO FLDCs. Double GTKO FLDCs were used in somatic cell nuclear transfer (SCNT) to create GTKO pigs.
RESULTS: FLDCs grew for more than 80 population doublings, maintaining normal karyotype. Gene targeting and loss of heterozygosity mutations produced homozygous GTKO FLDCs. FLDCs used in SCNT gave rise to homozygous GTKO pigs.
CONCLUSIONS: FDLCs can be used in gene targeting and SCNT to produce genetically modified pigs. The increased life span in culture compared to fetal fibroblasts may facilitate genetic engineering in the pig.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21962810     DOI: 10.1016/j.jss.2011.07.051

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  5 in total

1.  Evaluation of human and non-human primate antibody binding to pig cells lacking GGTA1/CMAH/β4GalNT2 genes.

Authors:  Jose L Estrada; Greg Martens; Ping Li; Andrew Adams; Kenneth A Newell; Mandy L Ford; James R Butler; Richard Sidner; Matt Tector; Joseph Tector
Journal:  Xenotransplantation       Date:  2015-03-01       Impact factor: 3.907

Review 2.  Recent advances in the development of new transgenic animal technology.

Authors:  Xiangyang Miao
Journal:  Cell Mol Life Sci       Date:  2012-07-26       Impact factor: 9.261

3.  Effects of donor fibroblast cell type and transferred cloned embryo number on the efficiency of pig cloning.

Authors:  Zicong Li; Junsong Shi; Dewu Liu; Rong Zhou; Haiyu Zeng; Xiu Zhou; Ranbiao Mai; Shaofen Zeng; Lvhua Luo; Wanxian Yu; Shouquan Zhang; Zhenfang Wu
Journal:  Cell Reprogram       Date:  2012-12-20       Impact factor: 1.987

4.  Alpha-1,3-galactosyltransferase-deficient miniature pigs produced by serial cloning using neonatal skin fibroblasts with loss of heterozygosity.

Authors:  Young June Kim; Kwang Sung Ahn; Minjeong Kim; Min Ju Kim; Jin Seop Ahn; Junghyun Ryu; Soon Young Heo; Sang-Min Park; Jee Hyun Kang; You Jung Choi; Hosup Shim
Journal:  Asian-Australas J Anim Sci       Date:  2016-03-30       Impact factor: 2.509

5.  Bone marrow mesenchymal stem cells as nuclear donors improve viability and health of cloned horses.

Authors:  R Olivera; L N Moro; R Jordan; N Pallarols; A Guglielminetti; C Luzzani; S G Miriuka; G Vichera
Journal:  Stem Cells Cloning       Date:  2018-02-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.